The Scientist

» drug development and culture

Most Recent

image: RNA Ebola Drug Clears Animal Study

RNA Ebola Drug Clears Animal Study

By | April 24, 2015

The short interfering RNA-based therapy TKM-Ebola protects monkeys from the viral strain still circulating in West Africa.


image: FDA Calls for Data on ALS Drug

FDA Calls for Data on ALS Drug

By | April 21, 2015

In the midst of a debate about an experimental drug’s early approval, the US Food and Drug Administration requests that full trial results be released.

1 Comment

image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.


image: Book Excerpt from <em>p53</em>

Book Excerpt from p53

By | April 1, 2015

In Chapter 12, "Of Mice and Men," author Sue Armstrong recounts the point at which researchers moved from working with p53 in tissue culture to studying the gene in animal models.


image: Capsule Reviews

Capsule Reviews

By | April 1, 2015

Junk DNA, Cuckoo, Sapiens, and Cool


image: Setbacks and Great Leaps

Setbacks and Great Leaps

By | April 1, 2015

The tale of p53, a widely studied tumor suppressor gene, illustrates the inventiveness of researchers who turn mishaps into discoveries.

1 Comment

image: The 2015 Salary Survey Is Complete

The 2015 Salary Survey Is Complete

By | March 13, 2015

Thanks to everyone who participated in this year's survey. Please check back in November for the results.


image: 23andMe Enters Drug Development

23andMe Enters Drug Development

By | March 12, 2015

The personal genomics firm announces plans to make medicines.

1 Comment

image: Book Excerpt from <em>Galileo’s Middle Finger</em>

Book Excerpt from Galileo’s Middle Finger

By | March 10, 2015

In Chapter 4, “A Show-Me State of Mind,” author Alice Dreger describes the start of her journey studying scientists who had conducted controversial research.

1 Comment

image: AbbVie Wins Bidding War for Cancer Drugmaker

AbbVie Wins Bidding War for Cancer Drugmaker

By | March 5, 2015

The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.


Popular Now

  1. Antidepressant Exerts Epigenetic Changes
  2. Inside a Lab Mouse’s High-Fat Diet
  3. Image of the Day: Mother’s Love
  4. Gut Bugs to Brain: You’re Stuffed
Horizon Discovery
Horizon Discovery
Life Technologies